US Broker Ratings

Fortrea Holdings Inc. (FTRE) Investor Outlook: Navigating Challenges and Opportunities in the Biotechnology Sector

Fortrea Holdings Inc. (NASDAQ: FTRE) is making waves in the biotechnology sector, with its robust focus on providing innovative solutions for biopharmaceutical product and medical device..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a 98.97% Potential Upside in the Biotech Sector

Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a U.S.-based biotechnology firm, has been generating buzz in the healthcare sector with its innovative approach to gene therapies targeting..

Valneva SE (VALN) Stock Analysis: Exploring a 45% Potential Upside in the Biotechnology Sector

Valneva SE (NASDAQ: VALN), a French biotech company, is making headlines in the healthcare sector with its strong revenue growth and promising pipeline of vaccines for..

CorMedix Inc. (CRMD) Stock Analysis: A 67% Upside Potential with Strong Buy Ratings

CorMedix Inc. (CRMD), a biopharmaceutical company based in Berkeley Heights, New Jersey, is drawing significant attention from investors in the biotechnology sector. Specializing in the development..

Cross Country Healthcare, Inc. (CCRN): Investor Outlook with a 53.80% Upside Potential

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands out in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Boca Raton, Florida, the company..

Zenas BioPharma (ZBIO) Stock Analysis: Unpacking the 38.65% Potential Upside in the Biotech Space

Zenas BioPharma, Inc. (ZBIO) is capturing investor attention with its promising potential upside of 38.65%, according to recent analyst ratings. This clinical-stage biopharmaceutical company is making..

Claritev Corporation (CTEV): Investor Outlook Highlights 21% Potential Upside Amidst Growth in Healthcare Data Solutions

Investors looking for opportunities in the healthcare technology sector may find Claritev Corporation (NASDAQ: CTEV) an intriguing prospect. Specializing in data analytics and cost management solutions..

Community Health Systems, Inc. (CYH): Investor Outlook on Healthcare Stock with Mixed Analyst Sentiment

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates an extensive network of medical facilities across the United States. Headquartered in..

Xencor, Inc. (XNCR)

⚠️ No article content returned.

..

Altimmune, Inc. (ALT) Stock Analysis: A 304% Potential Upside Awaits Investors in the Biotech Arena

Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, is grabbing investor attention with its promising pipeline and significant potential upside. Based in Gaithersburg, Maryland, Altimmune focuses on..

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring an 86% Upside Potential with Analyst Confidence

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with an impressive market capitalization of $1.02 billion. Specializing..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating the Healthcare Sector’s Growth Potential

Avadel Pharmaceuticals plc (NASDAQ: AVDL) represents a compelling opportunity in the healthcare sector, especially within the specialty and generic drug manufacturing industry. With a market capitalization..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Uncovering a 36% Potential Upside in Biotech

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a trailblazer in the biotechnology sector, is capturing investor attention with its innovative approach to treating neurodegenerative diseases. With a market..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring the 231.72% Potential Upside

Investors eyeing the biotechnology sector for promising opportunities might want to take a closer look at Capricor Therapeutics, Inc. (NASDAQ: CAPR). With a market capitalization of..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a 8.46% Potential Upside in the Healthcare Sector

InnovAge Holding Corp. (NASDAQ: INNV), a healthcare company specializing in senior care through the Program of All-Inclusive Care for the Elderly (PACE), has been capturing investor..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A Biotech Gamble with a 366% Potential Upside

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial-stage biopharmaceutical company, stands at the forefront of developing innovative cell therapies for treating metastatic melanoma and other solid tumor..

LENZ Therapeutics, Inc. (LENZ)

⚠️ No article content returned.

..

Upstream Bio, Inc. (UPB) Stock Analysis: Unveiling a 93% Potential Upside in Biotech

In the dynamic world of biotechnology, Upstream Bio, Inc. (NASDAQ: UPB) emerges as a promising player with substantial growth prospects. With its robust 93.05% potential upside,..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Exploring a 53% Potential Upside in Biotechnology

Keros Therapeutics, Inc. (NASDAQ: KROS) stands as a promising player in the biotechnology sector, drawing attention with its innovative approach to treating disorders linked to dysfunctional..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds